NCT01350440View on ClinicalTrials.gov

Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Spinocerebellar Ataxia
Interventions
BIOLOGICAL

IVIG

Intravenous Immune Globulin

Trial Locations (1)

33612

University of South Florida, Tampa

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

University of South Florida

OTHER

NCT01350440 - Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia | Biotech Hunter | Biotech Hunter